Transcranial Magnetic Stimulation for Patients with Exposure Therapy Resistant Obsessive-Compulsive Disorder (TETRO): Study Protocol for a Multicenter Randomized Controlled Trial
JMIR Research Protocols · 09.09.2026 · 15 · e94288-e94288
DOI: 10.2196/94288 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JMIR Research Protocols, online erschienen am 09.09.2026. Verfasst von Tjardo S Postma und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, North Holland, 1081HV, The Netherlands, …. Hauptthemen laut MEDLINE: Implosive Therapy, Obsessive-Compulsive Disorder, Transcranial Magnetic Stimulation. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Obsessive-compulsive disorder (OCD) is a disabling mental disorder, characterized by obsessions, compulsions, and substantial morbidity. Approximately 50% of adults with OCD fail to achieve satisfactory outcomes from first-line treatments, such as exposure therapy with response prevention (ERP), with or without medication. This leads to chronic social, educational, and occupational impairment. While invasive procedures such as deep brain stimulation are available for severe, treatment-refractory cases, a need remains for less invasive alternatives. Repetitive transcranial magnetic stimulation (rTMS), a noninvasive intervention, shows promise in reducing OCD symptoms. Unlike in depression, rTMS is not yet reimbursed for OCD in the Dutch healthcare system.
Objective
This study examines the efficacy and cost-effectiveness of low-frequency (1Hz) rTMS targeting the presupplementary motor area (pre-SMA) compared to sham rTMS as an adjuvant treatment to ERP in adults with OCD with inadequate response to first-line treatment.
Methods
A total of 250 adults with OCD will be enrolled in this multicenter randomized controlled trial. Participants will be randomly assigned to ERP combined with either active or sham 1Hz rTMS over the pre-SMA. Treatment is administered 4 times weekly for at least 5 weeks (20 rTMS-ERP sessions), with optional extension of 1 to 2 weeks, up to 28 rTMS-ERP sessions. Clinical assessments occur at baseline, weekly during treatment, posttreatment, and at 3, 6, and 12 months follow-up. Participants undergo pre- and posttreatment (functional) (MRI) scans, including a symptom provocation task. Blood sampling takes place pre- and posttreatment and at 3-month follow-up. The primary outcome is OCD severity at posttreatment, as measured by the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS). Secondary outcomes include functional improvement, quality of life, and societal costs. Pretreatment symptom profiles, genotype, and brain network topology will be analyzed as predictors of response and relapse risk. Pre-to-post treatment change in blood-based and magnetic resonance (MR)-based neuroplasticity markers will help explore differential mechanisms between ERP alone and combined rTMS-ERP. We expect that the verum rTMS protocol will be cost-effective compared to sham-rTMS.
Results
Recruitment started in April 2022, and as of February 2026, 201 participants have been enrolled. Posttreatment assessments are projected to be completed in December 2026, with final one-year follow-up evaluations anticipated by the end of 2027.
Conclusions
To our knowledge, this study is the first adequately powered randomized controlled trial examining efficacy, cost-effectiveness, and mechanism of action of rTMS for OCD as adjuvant therapy to ERP. In case of efficacy and/or cost-effectiveness, it will pave the way for rTMS as insured health care for adults with OCD in the Netherlands, and possibly other European countries. Furthermore, this trial will provide insight into the mechanisms of treatment response to intensive ERP, with and without adjunctive rTMS, as well as potential side effects, individual variability, and long-term outcomes in adults with OCD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, North Holland, 1081HV, The Netherlands, 31 0204444444.
- Department of Anatomy & Neurosciences, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, North Holland, The Netherlands.
- Impulsivity & Attention program, Amsterdam Neuroscience, Amsterdam, North Holland, The Netherlands.
- GGZ inGeest, Amsterdam, North Holland, The Netherlands.
- Brainclinics foundation, Brainclinics, Nijmegen, Gelderland, The Netherlands.
- Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, United States.
ORCID-Profile: Tjardo S Postma, Ysbrand D van der Werf, Martijn Arns, Neeltje M Batelaan, Judith E Bosmans, Merijn Eikelenboom, Gert-Jan Hendriks, Adriaan W Hoogendoorn, Mirjam Kampman, Iris van Oostrom, Patricia van Oppen, Alexander T Sack, Koen Schruers, Indira Tendolkar, Chris Vriend, Odile A van den Heuvel
Zitieren
APA
Postma, T. S., van der Werf, Y. D., Arns, M., Batelaan, N. M., van den Berg, M., Bosmans, J. E., Eikelenboom, M., Hendriks, G. J., Hoogendoorn, A. W., Kampman, M., van Leeuwen, D., van Oostrom, I., van Oppen, P., Sack, A. T., Schruers, K., Tendolkar, I., Vriend, C., & van den Heuvel, O. A. (2026). Transcranial Magnetic Stimulation for Patients with Exposure Therapy Resistant Obsessive-Compulsive Disorder (TETRO): Study Protocol for a Multicenter Randomized Controlled Trial. JMIR Research Protocols, 15, e94288-e94288. https://doi.org/10.2196/94288
Vancouver
Postma TS, van der Werf YD, Arns M, Batelaan NM, van den Berg M, Bosmans JE, et al. Transcranial Magnetic Stimulation for Patients with Exposure Therapy Resistant Obsessive-Compulsive Disorder (TETRO): Study Protocol for a Multicenter Randomized Controlled Trial. JMIR Research Protocols. 2026;15:e94288-e94288. doi:10.2196/94288
BibTeX
@article{Postma2026,
author = {Postma, Tjardo S and van der Werf, Ysbrand D and Arns, Martijn and Batelaan, Neeltje M and van den Berg, Manou and Bosmans, Judith E and Eikelenboom, Merijn and Hendriks, Gert-Jan and Hoogendoorn, Adriaan W and Kampman, Mirjam and van Leeuwen, Désirée and van Oostrom, Iris and van Oppen, Patricia and Sack, Alexander T and Schruers, Koen and Tendolkar, Indira and Vriend, Chris and van den Heuvel, Odile A},
title = {Transcranial Magnetic Stimulation for Patients with Exposure Therapy Resistant Obsessive-Compulsive Disorder (TETRO): Study Protocol for a Multicenter Randomized Controlled Trial},
journal = {JMIR Research Protocols},
year = {2026},
volume = {15},
pages = {e94288--e94288},
doi = {10.2196/94288}
}
EUVIMED